2.76
6.44%
-0.19
시간 외 거래:
2.64
-0.12
-4.35%
Biora Therapeutics Inc (BIOR) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
0.542
|
- | - | 0.002 | 0.002 |
Operating Expenses
|
20.34%
16.06
|
13.34 | 23.32 | 14.94 | 15.55 |
Interest Income/Expense |
49.84%
2.757
|
1.84 | 2.592 | 2.703 | 2.68 |
Benefits Costs and Expenses |
70.22%
4.683
|
15.73 | 73.45 | 17.80 | 17.44 |
Costs And Expenses |
70.22%
4.683
|
15.73 | 73.45 | 17.80 | 17.44 |
Depreciation and Amortization |
10.26%
0.105
|
0.117 | 0.125 | 0.166 | 0.147 |
Operating Income/Loss |
16.28%
-15.52
|
-13.34 | -23.32 | -14.93 | -15.54 |
Nonoperating Income/Loss |
101.63%
0.217
|
-13.28 | -52.11 | -0.005 | -0.081 |
Income/Loss From Continuing Operations Before Tax |
73.67%
-4.141
|
-15.73 | -73.45 | -17.80 | -17.44 |
Income Tax Expense/Benefit |
150.53%
0.048
|
-0.095 | 0.001 | 0.004 | - |
Income/Loss From Continuing Operations After Tax |
73.20%
-4.189
|
-15.63 | -73.45 | -17.81 | -17.44 |
Net Income/Loss
|
72.82%
-4.189
|
-15.41 | -73.45 | -17.81 | -17.44 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
861.92%
29.30
|
3.0456 | 15.02 | 12.14 | 10.97 |
Diluted Average Shares |
861.92%
29.30
|
3.0456 | 15.02 | 12.14 | 10.97 |
Basic Earnings Per Share |
120.90%
-0.14
|
0.67 | -4.89 | -1.47 | -1.59 |
Diluted Earnings Per Share |
120.90%
-0.14
|
0.67 | -4.89 | -1.47 | -1.59 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):